(Q42907440)

English

Abnormal findings on multiparametric prostate magnetic resonance imaging predict subsequent biopsy upgrade in patients with low risk prostate cancer managed with active surveillance

scientific article published on October 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 November 2017

Abnormal findings on multiparametric prostate magnetic resonance imaging predict subsequent biopsy upgrade in patients with low risk prostate cancer managed with active surveillance (English)

1 reference

Europe PubMed Central

10 November 2017

Richard Flavell

1

1 reference

Europe PubMed Central

10 November 2017

author name string

Antonio C Westphalen

2

1 reference

Europe PubMed Central

10 November 2017

Carmin Liang

3

1 reference

Europe PubMed Central

10 November 2017

Christopher C Sotto

4

1 reference

Europe PubMed Central

10 November 2017

Susan M Noworolski

5

1 reference

Europe PubMed Central

10 November 2017

Daniel B Vigneron

6

1 reference

Europe PubMed Central

10 November 2017

Zhen J Wang

7

1 reference

Europe PubMed Central

10 November 2017

John Kurhanewicz

8

1 reference

Europe PubMed Central

10 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 October 2014

1 reference

Europe PubMed Central

10 November 2017

Abdominal Imaging

1 reference

Europe PubMed Central

10 November 2017

39

1 reference

Europe PubMed Central

10 November 2017

5

1 reference

Europe PubMed Central

10 November 2017

1027-1035

1 reference

Europe PubMed Central

10 November 2017

Multiparametric magnetic resonance imaging characterization of prostate lesions in the active surveillance population: incremental value of magnetic resonance imaging for prediction of disease reclassification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169752

27 May 2018

Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169752

27 May 2018

Performance of multiparametric magnetic resonance imaging in the evaluation and management of clinically low-risk prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169752

27 May 2018

Multiparametric MRI of prostate cancer: an update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169752

27 May 2018

The role of MRI in active surveillance of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169752

27 May 2018

Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169752

27 May 2018

Multiparametric magnetic resonance imaging findings in men with low-risk prostate cancer followed using active surveillance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169752

27 May 2018

Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169752

27 May 2018

Active surveillance for prostate cancer: a systematic review of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169752

27 May 2018

MRI and surveillance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169752

27 May 2018

ESUR prostate MR guidelines 2012

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169752

27 May 2018

Predictive value of MRI in the localization, staging, volume estimation, assessment of aggressiveness, and guidance of radiotherapy and biopsies in prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169752

27 May 2018

Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169752

27 May 2018

Prostate cancer: multiparametric MR imaging for detection, localization, and staging.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169752

27 May 2018

Diffusion coefficient measurement using a temperature-controlled fluid for quality control in multicenter studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169752

27 May 2018

Advancements in MR imaging of the prostate: from diagnosis to interventions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169752

27 May 2018

Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169752

27 May 2018

Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169752

27 May 2018

Diffusion-weighted magnetic resonance imaging for monitoring prostate cancer progression in patients managed by active surveillance.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169752

27 May 2018

Prostate cancer managed with active surveillance: role of anatomic MR imaging and MR spectroscopic imaging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169752

27 May 2018

'Prostatic evasive anterior tumours': the role of magnetic resonance imaging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169752

27 May 2018

Radical prostatectomy findings in patients in whom active surveillance of prostate cancer fails

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169752

27 May 2018

Clinical application of BASING and spectral/spatial water and lipid suppression pulses for prostate cancer staging and localization by in vivo 3D 1H magnetic resonance spectroscopic imaging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169752

27 May 2018

Role of multiparametric 3.0-Tesla magnetic resonance imaging in patients with prostate cancer eligible for active surveillance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169752

16 August 2018

Tumor lesion diameter on diffusion weighted magnetic resonance imaging could help predict insignificant prostate cancer in patients eligible for active surveillance: preliminary analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169752

16 August 2018

Does suspicion of prostate cancer on integrated T2 and diffusion-weighted MRI predict more adverse pathology on radical prostatectomy?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169752

16 August 2018

MR spectroscopic imaging and diffusion-weighted imaging of prostate cancer with Gleason scores

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169752

16 August 2018

Clinical utility of apparent diffusion coefficient (ADC) values in patients with prostate cancer: can ADC values contribute to assess the aggressiveness of prostate cancer?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169752

16 August 2018

Simple linear measurements of the normal liver: interobserver agreement and correlation with hepatic volume on MRI.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169752

16 August 2018

Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169752

16 August 2018

Prostate cancer: is inapparent tumor at endorectal MR and MR spectroscopic imaging a favorable prognostic finding in patients who select active surveillance?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169752

16 August 2018

High-resolution 3D MR spectroscopic imaging of the prostate at 3 T with the MLEV-PRESS sequence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169752

16 August 2018

Diffusion-weighted MRI in prostate cancer -- comparison between single-shot fast spin echo and echo planar imaging sequences

1 reference

https://pubmed.ncbi.nlm.nih.gov/24740760

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dynamic Contrast-enhanced–magnetic Resonance Imaging Evaluation of Intraprostatic Prostate Cancer: Correlation with Radical Prostatectomy Specimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/24740760

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endorectal T2-weighted MRI does not differentiate between favorable and adverse pathologic features in men with prostate cancer who would qualify for active surveillance

1 reference

https://pubmed.ncbi.nlm.nih.gov/24740760

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Value of 3-T multiparametric magnetic resonance imaging and magnetic resonance-guided biopsy for early risk restratification in active surveillance of low-risk prostate cancer: a prospective multicenter cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24740760

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Initial experience with identifying high-grade prostate cancer using diffusion-weighted MR imaging (DWI) in patients with a Gleason score ≤ 3 + 3 = 6 upon schematic TRUS-guided biopsy: a radical prostatectomy correlated series

1 reference

https://pubmed.ncbi.nlm.nih.gov/24740760

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Study of Diffusion-Weighted Magnetic Resonance Imaging in Men with Untreated Localised Prostate Cancer on Active Surveillance

1 reference

https://pubmed.ncbi.nlm.nih.gov/24740760

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Apparent diffusion coefficient as a predictive biomarker of prostate cancer progression: value of fast and slow diffusion components

1 reference

https://pubmed.ncbi.nlm.nih.gov/24740760

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of Multiparametric Endorectal Coil Prostate Magnetic Resonance Imaging on Disease Reclassification Among Active Surveillance Candidates: A Prospective Cohort Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24740760

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Magnetic resonance imaging does not improve the prediction of misclassification of prostate cancer patients eligible for active surveillance when the most stringent selection criteria are based on the saturation biopsy scheme

1 reference

https://pubmed.ncbi.nlm.nih.gov/24740760

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00261-014-0136-7

1 reference

Europe PubMed Central

10 November 2017

1 reference

Europe PubMed Central

10 November 2017

1 reference

Europe PubMed Central

10 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42907440&oldid=1973485869"